Progress in the clinical development of CX-2051, targeted at advanced colorectal cancer, with initial Phase 1a clinical data expected in the first half of 2025. CytomX maintains a strong financial ...

CytomX Therapeutics has updated its pipeline priorities for 2025, highlighting its lead program, CX-2051, a first-in-class PROBODY ADC targeting EpCAM for advanced metastatic colorectal cancer, with ...

Customer experience (CX) programs that have been running for several years are often in a Catch-22: the program has lost buy-in because it is not perceived to produce actionable insights; however, ...

Despite the recent challenges in overall experience quality seen in Forrester’s Customer Experience Index (CX Index™) benchmarks, customer experience (CX) remains a priority for many organizations.

The Daniel Group, a leader in B2B customer experience, introduces the CX Institute, offering training and coaching to enhance CX programs. Leveraging insights from one million surveys, the initiative ...

With most economists expecting a recession this year, and some indicating that the country is already in one, Forrester Research is predicting that one-fifth of all customer experience programs could ...

Measuring customer experiences has long been a cornerstone of customer experience (CX) programs, yet traditional survey-based feedback methods are increasingly under pressure to evolve. As businesses ...